Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Bristol's High Profile TYK2 Inhibitor Disappoints In Ulcerative Colitis
07 Oct 2021
•
By
Jessica Merrill
Bristol's TYK2 inhibitor failed a Phase II study in ulcerative colitis • Source: Alamy
More from Immunological
More from Therapy Areas